Overview
- Secretary of Defense Pete Hegseth announced the program in a video on X, saying service members 30 and older will receive annual testosterone tests and younger personnel may opt in.
- The Pentagon said treatment will be voluntary and offered to people diagnosed with deficiency, but it has not released clinical thresholds, repeat‑testing rules, or guidance on fitness for duty.
- Major medical societies and specialists warn that routine screening without symptoms departs from standard practice because diagnosis normally requires compatible symptoms plus confirmatory morning blood tests.
- Lawmakers and advocates raised questions about gender equity and data handling, and some critics said the initiative fits broader administration moves that have eased access to testosterone therapies.
- The change could increase diagnoses and prescriptions for some service members and may affect deployment and personnel management once the Pentagon issues formal protocols.